{"SPADE_N_15848": {"Sequence Information": {"Peptide Name": "Tyrocidine B", "Sequence": "FPWFNQYVXL", "Sequence Length": 10, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antiparasitic", "Anticancer", "Antifungal", "Anti-Mammalian Cell", "Antibiofilm"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Bacillus aneurinolyticus\n2. Bacillus brevis", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Anti-listerial activity and structure-activity relationships of the six major tyrocidines, cyclic decapeptides from Bacillus aneurinolyticus.", "Pubmed ID": "19586775", "Reference": "Bioorg Med Chem. 2009;17:5541-5548", "Author": "Spathelf BM, Rautenbach M", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/19586775"}, {"Title": "Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.", "Pubmed ID": "24752256", "Reference": "Antimicrob Agents Chemother. 2014;58:3697-3707", "Author": "Troskie AM, Rautenbach M, Delattin N, Vosloo JA, Dathe M, Cammue BP, Thevissen K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24752256"}, {"Title": "Inhibition of malaria parasite blood stages by tyrocidines, membrane-active cyclic peptide antibiotics from Bacillus brevis.", "Pubmed ID": "17462586", "Reference": "Biochim Biophys Acta. 2007;1768:1488-1497", "Author": "Rautenbach M, Vlok NM, Stander M, Hoppe HC", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17462586"}, {"Title": "Antifungal membranolytic activity of the tyrocidines against filamentous plant fungi.", "Pubmed ID": "27328781", "Reference": "Biochimie. 2016;:", "Author": "Rautenbach M, Troskie AM, Vosloo JA, Dathe ME", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27328781"}], "SPADE ID": "SPADE_N_15848", "Similar Sequences": [{"SPADE_ID": "SPADE_N_06785", "Similarity": 1.0, "Sequence": "VLFPWFNQY"}, {"SPADE_ID": "SPADE_N_06786", "Similarity": 1.0, "Sequence": "VKLFPWFNQY"}, {"SPADE_ID": "SPADE_UN_16901", "Similarity": 1.0, "Sequence": "FPWFNQYVL"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=2.6 µM", "Target Organism": "Micrococcus luteus NCTC 8340(IC50=6.5±0.07µM),Micrococcus luteus NCTC 8340(MIC=9.9±0.13µM),Listeria monocytogenes B73(IC50=10±0.46µM),Listeria monocytogenes B73(MIC=15±0.41µM),Listeria monocytogenes B73-MR1(IC50=7.7±0.59µM),Listeria monocytogenes B73-MR1(MIC=12±0.28µM),Escherichia coli HB101(IC50=>250µM),Candida albicans SC5314(MIC=6.25±0.00µM),Candida albicans SC5314(MIC50=4.31±0.03µM),Plasmodium falciparum 3D7(IC50=0.061µM),Human cervical carcinoma HeLa(LC50=17µM),Human lung carcinoma A549(LC50=12µM),Botrytis cinerea CKJ 1731(IC50=2.1 ± 0.3µM),Fusarium solani STEU 6188(IC50=5.3±0.2µM),Aspergillus fumigatus ATCC 204305(IC50=2.5±0.2µM)"}}}